Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood...

Managing systemic blood pressure involves balancing systolic and diastolic targets to prevent long-term organ damage and vascular complications. Prior research has shown that elevated systolic readings significantly contribute to the development of stroke and myocardial infarction in aging populations. Clinicians often focus on achieving specific systolic thresholds while diastolic levels fluctuate significantly during intensive pharmacological therapy. The prognostic significance of extreme diastolic variations remains poorly understood when systolic levels are successfully controlled below standard clinical targets. Existing literature provides conflicting data regarding the safety of very low diastolic readings in older populations with multiple comorbidities. This absence of evidence motivated a detailed investigation into how isolated diastolic deviations influence long-term patient outcomes within a large-scale clinical trial.

This investigation evaluated the association between treated isolated diastolic hypertension or low diastolic pressure and major adverse cardiovascular events in hypertensive patients. Researchers sought to clarify whether patients with normalized systolic readings face residual risks from diastolic outliers during intensive treatment. The study specifically targeted individuals whose systolic blood pressure remained below 130 mm Hg under medical supervision to isolate diastolic effects. By categorizing patients based on their average diastolic measurements, the team aimed to identify specific risk thresholds for clinical monitoring. Understanding these relationships helps refine treatment protocols for hypertensive populations receiving intensive pharmacological intervention to maximize safety. The analysis focused on determining if isolated diastolic hypertension or low diastolic pressure independently predicts cardiovascular complications when systolic goals are met.

Investigators conducted a secondary analysis using data from 7,582 participants enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT) to ensure a robust sample size. Study subjects were required to maintain an on-treatment systolic blood pressure of less than 130 mm Hg throughout the observation period. The cohort was stratified into three distinct groups based on average Diastolic Blood Pressure (DBP): below 60 mm Hg (n=1031), 60 to 79 mm Hg (n=5432), and 80 mm Hg or higher (n=1119). Cox proportional-hazards models served as the primary statistical framework for estimating the risk of Major Adverse Cardiovascular Events (MACEs) across these categories. Researchers monitored participants over a median follow-up period of 3.4 years to track clinical outcomes including myocardial infarction and heart failure. The median age of the study population was 67.0 years, and men comprised approximately 64.9% of the total participant group. Statistical tests for interaction assessed whether age, sex, or prior cardiovascular disease history modified the observed associations between diastolic levels and outcomes.

Patients with isolated low diastolic blood pressure exhibited a 1.32-fold increased risk of major adverse cardiovascular events compared to the reference group. The incidence rate for these events reached 3.9 cases per 100 person-years in the group with diastolic readings below 60 mm Hg. In contrast, individuals with diastolic levels between 60 and 79 mm Hg experienced a lower incidence of 1.9 cases per 100 person-years. The group with treated isolated diastolic hypertension showed an incidence of 1.8 cases per 100 person-years and no significant risk increase. Statistical analysis yielded a hazard ratio of 1.32 for the low diastolic group with a 95% confidence interval ranging from 1.05 to 1.66. No significant effect modification occurred across subgroups defined by sex, age, or atherosclerotic cardiovascular disease risk scores, as all interaction p-values exceeded 0.05. Over the course of the study, 512 patients developed a major adverse cardiovascular event, providing sufficient data for robust hazard estimation.

Excessively low diastolic blood pressure represents a significant risk factor for cardiovascular complications even when systolic pressure is successfully controlled. These findings suggest that clinicians should monitor for isolated low diastolic blood pressure during intensive antihypertensive therapy to avoid potential harm. The lack of association between isolated diastolic hypertension and adverse events implies that systolic control remains the primary prognostic driver in this population. Future management strategies for hypertension may need to incorporate specific safeguards against over-reduction of diastolic levels to optimize patient safety. Additional research must determine the optimal therapeutic window for diastolic pressure in patients with normalized systolic readings across diverse clinical settings. Identifying the physiological mechanisms behind low diastolic risk could improve long-term survival in high-risk hypertensive cohorts undergoing intensive treatment. The study emphasizes that while systolic targets are vital, the diastolic floor may be equally important for preventing major adverse cardiovascular events.